Status:
NOT_YET_RECRUITING
Body Composition in Pediatric Patients With Thalassemia Major
Lead Sponsor:
Assiut University
Conditions:
Body Composition in Thalassemia Major
Eligibility:
All Genders
5-18 years
Brief Summary
To assess body composition (fat mass, lean mass, and bone mass) in pediatric patients with beta thalassemia major using appropriate tools (e.g.,Bioelectrical impedance analysis (BIA)). To evaluate th...
Detailed Description
Thalassemias are severe inherited anemias characterized by microcytic, hypochromic, and short-lived red blood cells due to defective hemoglobin synthesis(1) β-thalassemias are a heterogeneous group of...
Eligibility Criteria
Inclusion
- Children aged 5-18 years
- Diagnosed with beta thalassemia major
- Receiving regular transfusions
- Informed consent/assent provided.
Exclusion
- Presence of other chronic systemic diseases
- On medications that significantly affect body composition (e.g., steroids)
- Severe physical or cognitive disability interfering with assessment
Key Trial Info
Start Date :
October 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
115 Patients enrolled
Trial Details
Trial ID
NCT07204015
Start Date
October 1 2025
End Date
December 1 2026
Last Update
October 2 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.